News

AMSBIO offers a comprehensive range of high quality Heparan Sulfate (HS) antibodies from F69-3G10, F58-10E4 and JM403 clones, which have been proven ideal for targeted binding of HS in Heparan Sulfate Proteoglycans (HSPG) research.

Falmouth, UK, 3rd September 2019 / A recent study from Watson-Marlow Fluid Technology Group (WMFTG), demonstrates that PureWeld XL tubing offers extended lifespan and steady flow consistency when compared to other leading brands. Dr Chris Palmer, Tubing Product Manager at WMFTG, will share the results of the study at The Single Use Event, Antwerp on 10th September.

Cambridge, UK, 27 August 2019: Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, today introduced an updated version of its Cyto-Mine® Studio Software Suite, a collection of software controlling operation of its Cyto-Mine Single Cell Analysis System, data acquisition and follow-up analysis. The latest software version includes new functionality to further enhance users’ workflows in biologics discovery and cell line development.

20th August 2019: Marks & Clerk, the UK’s largest Patent and Trade Mark Attorney firm, has boosted its team in Cambridge with the promotion of two new Partners. Steven Gurney, a specialist in the pharmaceutical sector and Matthew Pinney who specialises in software and telecommunications, both join the Marks & Clerk partnership.


The firm, which alongside its office in Cambridge has bases across the UK as well as in the EU, North America and Asia, is one of Europe’s largest teams of intellectual property specialists.

Cambridge, UK, 21 August 2019: Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, announced today that it has opened a new office space at Granta Park in Cambridgeshire, UK. The new facilities support the Company’s accelerated expansion and accommodate its plans for further growth.

Cambridge, UK, 20 August: PredictImmune, developers of pioneering prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases, is delighted to welcome Tim Rea, an investor at BGF, to its board.


Tim has been active in the venture capital and start-up ecosystem for over 20 years across a broad range of sectors, stages and geographies. He is particularly passionate about the application of new, disruptive technologies into the healthcare and life sciences ecosystems.

Eastern AHSN has published its latest impact review which celebrates its impact for the last financial year, told largely through the stories of the people it has worked with.

This research, which investigates the risk of drug-induced folate deficiency with HIV integrase inhibitors, was published in Drug Metabolism and Disposition (DMD)

QxMD Builds on Medscape’s Point-of-Care Tools and Services


New York, NY, August 12, 2019: WebMD Health Corp., an Internet Brands company and the leader in health information services for physicians and consumers, has acquired QxMD, a Vancouver, BC-based learning technology company that delivers mobile decision point tools and personalized learning solutions for physicians and health care professionals (HCPs).

Research Triangle Park, N.C. (Aug. 13, 2019) – AskBio, the world’s foremost clinical stage and gene therapy platform company, has acquired Synpromics, the leader in gene control synthetic promoter technology, bioinformatics and intelligent data-driven design that enables more precise cell targeting and gene expression. Synpromics will operate as a wholly owned subsidiary and remain headquartered in Edinburgh, United Kingdom.

Pages